HIV Monitoring for People Receiving Long Acting PrEP
Listen to Jonathan Appelbaum, MD, FACP, AAHIVS, discuss updated CDC guidance on why and how to monitor for HIV in people receiving LA PrEP.
Decera Clinical Education Infectious Disease Podcast · Jonathan Appelbaum MD FACP AAHIVS
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Jonathan Appelbaum, MD, FACP, AAHIVS, discusses the updated CDC guidance on how to monitor for HIV in people receiving PrEP, including:
- Rationale for why HIV monitoring differs for people receiving LA vs daily PrEP
- Description of LEVI syndrome
- How to transition a person from LA PrEP to HIV ART if they test positive for HIV
Presenter:
Jonathan Appelbaum, MD, FACP, AAHIVS
Laurie L. Dozier, Jr., MD Education Director and Professor of Internal Medicine
Chair, Department of Clinical Sciences
Florida State University College of Medicine
Medical Director
Care Point Health and Wellness
Tallahassee, Florida
Link to the full program:
https://bit.ly/49x0W6D
Link to the slideset:
https://bit.ly/4bzZoth
To get access to all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.